Patent ID: 8900588

Claim:
A method for treating breast cancer, comprising the step of administering to a patient in need of treatment for breast cancer a therapeutically effective amount of a composition comprising a neutralizing anti-hPG monoclonal antibody that specifically binds to hPG and competes for binding to hPG with a reference antibody selected from: (a) a monoclonal antibody comprising a heavy variable domain sequence of SEQ ID NO:12 and a light chain variable domain sequence of SEQ ID NO:13; (b) a monoclonal antibody comprising a heavy variable domain sequence of SEQ ID NO:59 and a light chain variable domain sequence of SEQ ID NO:63; (c) a monoclonal antibody comprising a heavy variable domain sequence of SEQ ID NO:60 and a light chain variable domain sequence of SEQ ID NO:64; (d) a monoclonal antibody comprising a heavy variable domain sequence of SEQ ID NO:61 and a light chain variable domain sequence of SEQ ID NO:65; and (e) a monoclonal antibody comprising a heavy variable domain sequence of SEQ ID NO:62 and a light chain variable domain sequence of SEQ ID NO:66.